Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
HC Bioscience, a US-based tRNA-based drug discovery and development spinout of University of Iowa, has completed a $24m series A round co-led by Arch Venture Partners, 8VC and Takeda Ventures, a strategic investment unit of pharmaceutical firm Takeda. Verdox, a US-based carbon capture technology developer spun out of Massachusetts Institute of Technology, has picked up…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
